FR15C0035I1 - - Google Patents

Info

Publication number
FR15C0035I1
FR15C0035I1 FR15C0035C FR15C0035I1 FR 15C0035 I1 FR15C0035 I1 FR 15C0035I1 FR 15C0035 C FR15C0035 C FR 15C0035C FR 15C0035 I1 FR15C0035 I1 FR 15C0035I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR15C0035(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR15C0035I1 publication Critical patent/FR15C0035I1/fr
Application granted granted Critical
Publication of FR15C0035I2 publication Critical patent/FR15C0035I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
FR15C0035C 1998-05-15 2015-05-06 2-PHENYL-1-4-(2-AMINOETHOXY)-BENZYL]-INDOLE IN COMBINATION WITH ESTROGENS Active FR15C0035I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15
PCT/US1999/010217 WO1999059581A1 (en) 1998-05-15 1999-05-11 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens

Publications (2)

Publication Number Publication Date
FR15C0035I1 true FR15C0035I1 (en) 2015-06-26
FR15C0035I2 FR15C0035I2 (en) 2015-08-28

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
FR15C0035C Active FR15C0035I2 (en) 1998-05-15 2015-05-06 2-PHENYL-1-4-(2-AMINOETHOXY)-BENZYL]-INDOLE IN COMBINATION WITH ESTROGENS

Country Status (42)

Country Link
EP (1) EP1076558B1 (en)
JP (3) JP2002515431A (en)
KR (1) KR100620772B1 (en)
CN (1) CN1230163C (en)
AP (1) AP1424A (en)
AR (1) AR020074A1 (en)
AT (1) ATE245026T1 (en)
AU (1) AU760378B2 (en)
BE (1) BE2015C026I2 (en)
BG (1) BG64783B1 (en)
BR (1) BR9911040A (en)
CA (1) CA2329530A1 (en)
CU (1) CU23241B7 (en)
CY (1) CY2015020I1 (en)
CZ (1) CZ299334B6 (en)
DE (1) DE69909616T2 (en)
DK (1) DK1076558T3 (en)
EA (1) EA005932B1 (en)
EE (1) EE04262B1 (en)
ES (1) ES2203131T3 (en)
FR (1) FR15C0035I2 (en)
GE (1) GEP20033079B (en)
HK (1) HK1031691A1 (en)
HR (1) HRP20000778B1 (en)
HU (2) HU226587B1 (en)
ID (1) ID26890A (en)
IL (1) IL139130A (en)
IN (1) IN192220B (en)
LT (1) LTC1076558I2 (en)
LU (1) LU92699I2 (en)
NO (2) NO328129B1 (en)
NZ (1) NZ508200A (en)
OA (1) OA11552A (en)
PL (1) PL194750B1 (en)
PT (1) PT1076558E (en)
SI (1) SI1076558T1 (en)
SK (1) SK284666B6 (en)
TR (1) TR200003377T2 (en)
TW (1) TW565554B (en)
UA (1) UA66861C2 (en)
WO (1) WO1999059581A1 (en)
ZA (1) ZA200006959B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100620772B1 (en) * 1998-05-15 2006-09-13 와이어쓰 Pharmaceutical composition comprising estrogens and 2-phenyl-1-[4-2-aminoethoxy-benzyl]-indole
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
JP4790178B2 (en) 1999-07-06 2011-10-12 アンドルシェルシュ・インコーポレイテッド Method for treating and / or suppressing weight gain
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
WO2002003992A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating prosthesis-related bone degeneration
MXPA02012896A (en) * 2000-07-06 2003-10-24 Wyeth Corp Combinations of statins, estrogenic agents and optionally estrogens.
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
CA2415052A1 (en) * 2000-07-06 2002-01-17 Wyeth Combinations of bisphosphonates, estrogenic agents and optionally estrogens
DE10117441A1 (en) * 2001-04-03 2002-10-10 Schering Ag 1-indolyl derivatives, their use in the manufacture of medicaments, a process for the preparation of 1-indolyl derivatives and pharmaceutical preparations containing 1-indolyl derivatives
JP2005504032A (en) 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク Pharmaceutical compositions, kits and methods comprising estrogen agonist / antagonist, estrogen and progestin combinations
KR100470274B1 (en) 2002-11-08 2005-02-05 진 장 Method of phase transition of amorphous material using a cap layer
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (en) * 2005-01-07 2007-03-09 Sanofi Aventis Sa N- (HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
DK2276732T3 (en) 2008-04-16 2015-08-17 Karobio Ab Novel østrogenreceptorligander
AR072297A1 (en) * 2008-06-27 2010-08-18 Novartis Ag DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (en) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 New synthetic method of bazedoxifene
CN103709090A (en) * 2014-01-16 2014-04-09 江苏万特制药有限公司 Preparation method of bazedoxifene acetate and key intermediate thereof
CN103739540B (en) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 A kind of preparation method of bazedoxifene acetate intermediate
CN105669518B (en) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 The preparation method of bazedoxifene acetate and its A crystal form
EP3724183B1 (en) * 2017-12-15 2022-08-17 Bristol-Myers Squibb Company Substituted indole ether compounds
IT201800006562A1 (en) 2018-06-21 2019-12-21 PROCEDURE AND USEFUL INTERMEDIATES FOR THE PREPARATION OF INDOLES
JP2023517393A (en) * 2020-03-17 2023-04-25 メッドシャイン ディスカバリー インコーポレイテッド Proteolytic modifier and method of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
WO1993023374A1 (en) * 1992-05-08 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Indole derivative
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (en) * 1994-07-27 1996-03-14 Schering Ag 2-phenylindoles, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of medicaments
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
ATE206701T1 (en) * 1996-04-19 2001-10-15 American Home Prod ESTROGENIC COMPOUNDS
ATE277037T1 (en) * 1996-07-09 2004-10-15 Nikem Research Srl INDOLE DERIVATIVES FOR THE TREATMENT OF OSTEOPOROSIS
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
SI1025077T1 (en) * 1997-10-15 2007-06-30 Wyeth Corp Novel aryloxy-alkyl-dialkylamines
CA2308069A1 (en) * 1997-10-28 1999-05-06 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
UA68365C2 (en) * 1997-11-06 2004-08-16 Wyeth Corp Peroral contraception by combination of anti-estrogen and progestin
KR100620772B1 (en) * 1998-05-15 2006-09-13 와이어쓰 Pharmaceutical composition comprising estrogens and 2-phenyl-1-[4-2-aminoethoxy-benzyl]-indole

Also Published As

Publication number Publication date
BG64783B1 (en) 2006-04-28
AU760378B2 (en) 2003-05-15
AR020074A1 (en) 2002-04-10
AP2000001970A0 (en) 2000-12-31
JP2002515431A (en) 2002-05-28
KR20010043641A (en) 2001-05-25
OA11552A (en) 2004-06-07
UA66861C2 (en) 2004-06-15
DE69909616T2 (en) 2004-06-17
HUS1500023I1 (en) 2017-03-28
HK1031691A1 (en) 2001-06-22
BR9911040A (en) 2001-02-13
CN1326347A (en) 2001-12-12
ZA200006959B (en) 2001-11-27
HRP20000778B1 (en) 2004-10-31
LTC1076558I2 (en) 2016-11-10
DE69909616D1 (en) 2003-08-21
LU92699I2 (en) 2015-06-24
ID26890A (en) 2001-02-15
CN1230163C (en) 2005-12-07
JP2009019042A (en) 2009-01-29
EA005932B1 (en) 2005-08-25
AP1424A (en) 2005-06-06
NO2015015I1 (en) 2015-06-02
EE200000652A (en) 2002-04-15
WO1999059581A1 (en) 1999-11-25
BG104930A (en) 2001-07-31
HUP0103096A2 (en) 2002-05-29
ATE245026T1 (en) 2003-08-15
EE04262B1 (en) 2004-04-15
PL194750B1 (en) 2007-06-29
JP5607871B2 (en) 2014-10-15
KR100620772B1 (en) 2006-09-13
CY2015020I1 (en) 2020-05-29
NO20005770L (en) 2001-01-12
NO328129B1 (en) 2009-12-14
IN192220B (en) 2004-03-20
PL345268A1 (en) 2001-12-03
ES2203131T3 (en) 2004-04-01
JP2014159472A (en) 2014-09-04
CZ299334B6 (en) 2008-06-25
EP1076558B1 (en) 2003-07-16
NZ508200A (en) 2003-09-26
TW565554B (en) 2003-12-11
JP5872624B2 (en) 2016-03-01
SK284666B6 (en) 2005-08-04
NO2015015I2 (en) 2015-06-02
GEP20033079B (en) 2003-10-27
SK17202000A3 (en) 2001-07-10
HU226587B1 (en) 2009-04-28
HUP0103096A3 (en) 2002-11-28
HRP20000778A2 (en) 2001-06-30
SI1076558T1 (en) 2003-10-31
EP1076558A1 (en) 2001-02-21
PT1076558E (en) 2003-11-28
IL139130A0 (en) 2001-11-25
BE2015C026I2 (en) 2018-08-24
CU23241B7 (en) 2007-10-17
IL139130A (en) 2005-11-20
NO20005770D0 (en) 2000-11-14
FR15C0035I2 (en) 2015-08-28
DK1076558T3 (en) 2003-11-03
TR200003377T2 (en) 2001-03-21
EA200001193A1 (en) 2001-12-24
CA2329530A1 (en) 1999-11-25
AU3894499A (en) 1999-12-06
CZ20004254A3 (en) 2001-12-12

Similar Documents

Publication Publication Date Title
FR15C0035I1 (en)
BE2009C051I2 (en)
BRPI9914151B8 (en)
JP2002500500A5 (en)
JP2001521725A5 (en)
BRPI9816295A2 (en)
IN191331B (en)
JP2569812C (en)
JP2539845Z (en)
JP2530645C (en)
IN183733B (en)
JP2512091Z (en)
JP2523608Z (en)
JP2522224Z (en)
CN3073964S (en)
CN3076976S (en)
CN3081515S (en)
CN3072873S (en)
CN3084033S (en)
CN3072688S (en)
CL1998003164A1 (en)
CN3082609S (en)
CN3073771S (en)
BY6371C1 (en)
CN3085266S (en)